Robert Mittendorff

Robert Mittendorff, MD, MBA, currently serves as a General Partner and Head of Healthcare at B Capital Group since March 2021. In addition to this role, Robert holds various leadership positions on multiple boards, including Nalu Medical, Inc., Capital Rx, CARRICK THERAPEUTICS UK LIMITED, Carlsmed, Lively, Inc., HotSpot Therapeutics, Inc., and Triumvira Immunologics, Inc. Robert is also a board observer for Aetion and Volastra Therapeutics. Academic credentials include an MBA from Harvard Business School and an MD from Harvard Medical School, along with a Master of Arts in International Affairs from King's College London. Robert also possesses a Bachelor's degree in Biomedical/Electrical Engineering (high honors) from The Johns Hopkins University and has completed an Emergency Medicine Residency at Stanford University School of Medicine, in addition to pursuing a Graduate Program in Systems Engineering/Financial Engineering at MIT.